What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
His primary scientific interests are in Diabetes mellitus, Internal medicine, Type 2 diabetes, Endocrinology and Insulin resistance.
His Diabetes mellitus research includes themes of Cross-sectional study, Research design and Surgery.
His work in Research design addresses subjects such as Managed care, which are connected to disciplines such as Health education.
His Type 2 diabetes research incorporates elements of Type 1 diabetes and Type 2 Diabetes Mellitus.
His research in Insulin resistance intersects with topics in Body mass index and Beta.
Within one scientific family, Andrew J. Karter focuses on topics pertaining to Socioeconomic status under Glycemic, and may sometimes address concerns connected to Disease.
His most cited work include:
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus (748 citations)
- Ethnic Disparities in Diabetic Complications in an Insured Population (686 citations)
- The relation of body fat mass and distribution to markers of chronic inflammation. (579 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Diabetes mellitus, Internal medicine, Type 2 diabetes, Gerontology and Glycemic.
His biological study spans a wide range of topics, including Cohort study, Managed care, Research design, Insulin and Cohort.
His work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine.
His Type 2 diabetes research integrates issues from Hypoglycemia, Body mass index, Obesity, Dementia and Pediatrics.
His Gerontology study combines topics in areas such as Socioeconomic status, Incidence and Health education, Public health.
He has included themes like Glycated hemoglobin and Environmental health in his Glycemic study.
He most often published in these fields:
- Diabetes mellitus (79.31%)
- Internal medicine (38.97%)
- Type 2 diabetes (30.69%)
What were the highlights of his more recent work (between 2018-2021)?
- Diabetes mellitus (79.31%)
- Type 1 diabetes (10.00%)
- Type 2 diabetes (30.69%)
In recent papers he was focusing on the following fields of study:
Andrew J. Karter mainly investigates Diabetes mellitus, Type 1 diabetes, Type 2 diabetes, Internal medicine and Health literacy.
Andrew J. Karter works in the field of Diabetes mellitus, namely Glycemic.
His work carried out in the field of Type 1 diabetes brings together such families of science as Cognition, Pediatrics, Risk factor and Longevity.
His Type 2 diabetes research is multidisciplinary, incorporating perspectives in Hypoglycemia, Phacoemulsification, Diabetic retinopathy, Emergency department and Emergency medicine.
His research on Internal medicine frequently connects to adjacent areas such as Racial differences.
His Health literacy research incorporates elements of Computational linguistics and Nursing.
Between 2018 and 2021, his most popular works were:
- The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (the Diabetes & Aging Study) (100 citations)
- Using natural language processing and machine learning to classify health literacy from secure messages: The ECLIPPSE study. (11 citations)
- Severe Hypoglycemia and Cognitive Function in Older Adults With Type 1 Diabetes: The Study of Longevity in Diabetes (SOLID) (8 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Disease
Diabetes mellitus, Type 2 diabetes, Internal medicine, Health literacy and Pediatrics are his primary areas of study.
His Diabetes mellitus research is multidisciplinary, incorporating elements of Research design and Odds ratio.
His Type 2 diabetes research includes themes of Kidney disease, Revalidation, Emergency department, Medicaid and Emergency medicine.
His Internal medicine study combines topics in areas such as Metric and Cardiology.
The Pediatrics study combines topics in areas such as Dementia and Glycemic.
His research in Dementia tackles topics such as Cohort which are related to areas like Type 1 diabetes.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
